Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo

Blood

Volumn 94, Issue 9, 1999, Pages 3067-3076

  Cutrona, Giovanna ^a   Leanza, Nicolò ^b   Ulivi, Massimo ^b   Melioli, Giovanni ^b   Burgio, Vito L ^b   Mazzarello, Giovanni ^b   Gabutti, Giovanni ^b   Roncella, Silvio ^b   Ferrarini, Manlio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ETOPOSIDE; FAS ANTIGEN; MONOCLONAL ANTIBODY; STAUROSPORINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0033229711     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.9.3067     Document Type: Article

References (68)

1. Newman RA, Sutherland R, Greaves MF: The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors. J Immunol 126:2024, 1981
2. Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J, Reinherz EL: Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci USA 85:4819, 1988
3. LeBien TW, McCormack RT: The common acute lymphoblastic leukemia antigen (CD10) - Emancipation from a functional enigma. Blood 73:625, 1989
4. Shipp MA, Look AT: Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key! Blood 82:1052, 1993
5. Brown G, Hogg N, Greaves M: Candidate leukaemia-specific antigen in man. Nature 258:454, 1975
6. Metzgar RS, Borowitz MJ, Jones NH, Dowell BL: Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med 154:1249, 1981
7. Platt JL, LeBien TW, Michael AF: Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med 157:155, 1983
8. Braun MP, Martin PJ, Ledbetter JA, Hansen JA: Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood 61:718, 1983
9. Loke SL, Leung CY, Chiu KY, Yau WL, Cheung KN, Ma L: Localization of CD10 to biliary canaliculi by immunoelectron microscopical examination. J Clin Pathol 43:654, 1990
10. Gusterson BA, Monaghan P, Mahendran R, Ellis J, O'Hare MJ: Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J Natl Cancer Inst 77:343, 1986
11. Sunday ME, Hua J, Torday JS, Reyes B, Shipp MA: CD10/ neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest 90:2517, 1992
12. Zajac JM, Charnay Y, Soleilhic JM, Sales N, Roques BP: Enkephalin-degrading enzymes and angiotensin-converting enzyme in human and rat meninges. FEBS Lett 216:118, 1987
13. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC: High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276:523, 1978
14. Greaves M, Delia D, Janossy G, Rapson N, Chessells J, Woods M, Prentice G: Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. Leuk Res 4:15, 1980
15. Hokland P, Rosenthal P, Griffin JD, Nadler LM, Daley J, Hokland M, Schlossman SF, Ritz J: Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med 157:114, 1983
16. Neudorf SM, LeBien TW, Kersey JH: Characterization of thymocytes expressing the common acute lymphoblastic leukemia antigen. Leuk Res 8:173, 1984
17. Keating A, Whalen CK, Singer JW: Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): Implications for marrow transplantation. Br J Haematol 55:623, 1983
18. Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, Ritz J: Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 61:628, 1983
19. Liu YJ, Johnson GD, Gordon J, MacLennan IC: Germinal centres in T-cell-dependent antibody responses. Immunol Today 13:17, 1992
20. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group [see comments]. Blood 84:1361, 1994
21. Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu YJ: Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 183:971, 1996
22. Cutrona G, Dono M, Pastorino S, Ulivi M, Burgio VL, Zupo S, Roncella S, Ferrarini M: The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. Eur J Immunol 27:234, 1997
23. Dono M, Burgio VL, Tacchetti C, Favre A, Augliera A, Zupo S, Taborelli G, Chiorazzi N, Grossi CE, Ferrarini M: Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol 26:2035, 1996
24. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743, 1987
25. Henderson S, Rowe M, Gregory C, Croom Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
26. Cutrona G, Ulivi M, Fais F, Roncella S, Ferrarini M: Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J Exp Med 181:699, 1995
27. Polack A, Hortnagel K, Pajic A, Christoph B, Baier B, Falk M, Mautner J, Geltinger C, Bomkamm GW, Kempkes B: c-myc activation renders proliferation of Epstein-Barr virus (Ebv)-transformed cells independent of Ebv nuclear antigen 2 and latent membrane protein 1. Proc Natl Acad Sci USA 93:10411, 1996
28. De-Rossi A, Ometto L, Roncella S, D'Andrea E, Menin C, Calderazzo F, Rowe M, Ferrarini M, Chieco Bianchi L: HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: A model for a persistent "self-limiting" HIV-1 infection. Virology 198:234, 1994
29. From the Centers for Disease Control and Prevention. Update: Trends in AIDS diagnosis and reporting under the expanded surveillance definition for adolescents and adults - United States, 1993. JAMA 272:1815, 1994
30. Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026, 1988
31. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497, 1995
32. Roncella S, Di Celle PF, Cutrona G, Carbone A, Sessarego M, Dodi F, Foa R, Rowe M, Ferrarini M: Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas. Leukemia 3:12S, 1992 (suppl 6)
33. Atherton AJ, O'Hare MJ, Buluwela L, Titley J, Monaghan P, Paterson HF, Warburton MJ, Gusterson BA: Ectoenzyme regulation by phenotypically distinct fibroblast sub-populations isolated from the human mammary gland. J Cell Sci 107:2931, 1994
34. Graves JD, Draves KE, Craxton A, Krebs EG, Clark EA: A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. J Immunol 161:168, 1998
35. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
36. Nicholson DW: ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat Biotechnol 14:297, 1996
37. Katsikis PD, Garcia Ojeda ME, Torres Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA: Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med 186:1365, 1997
38. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
39. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin-V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
40. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053, 1999
41. Samejima K, Svingen PA, Basi GS, Kottke T, Mesner PW, Jr, Stewart L, Durrieu F, Poirier GG, Alnemri ES, Champoux JJ, Kaufmann SH, Earnshaw WC: Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J Biol Chem 274:4335, 1999
42. Newell MK, Haughn LJ, Maroun CR, Julius MH: Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347:286, 1990
43. Deng G, Podack ER: Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 90:2189, 1993
44. Ameisen JC: Programmed cell death and AIDS: From hypothesis to experiment. Immunol Today 13:388, 1992
45. Gougeon ML, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guetard D, Rame V, Dauguet C, Montagnier L: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 9:553, 1993
46. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F: Programmed death of T cells in HTV-1 infection. Science 257:217, 1992
47. Finkel TH, Tudor Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat Med 1:129, 1995
48. Muro Cacho CA, Pantaleo G, Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154:5555, 1995
49. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV: In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 102:79, 1998
50. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM: The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99:1546, 1997
51. Sloand EM, Maciejewski JP, Sato T, Bruny J, Kumar P, Kim S, Weichold FF, Young NS: The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J Clin Invest 101:195, 1998
52. Swat W, Ignatowicz L, von Boehmer H, Kisielow P: Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150, 1991
53. Page DM, Kane LP, Allison JP, Hedrick SM: Two signals are required for negative selection of CD4+CD8+ thymocytes. J Immunol 151:1868, 1993
54. Connelly JC, Skidgel RA, Schulz WW, Johnson AR, Erdos EG: Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide. Proc Natl Acad Sci USA 82:8737, 1985
55. Gros C, Souque A, Schwartz JC, Duchier J, Cournot A, Baumer P, Lecomte JM: Protection of atrial natriuretic factor against degradation: Diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Proc Natl Acad Sci USA 86:7580, 1989
56. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB: The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 265:14150, 1990
57. Mumford RA, Pierzchala PA, Strauss AW, Zimmerman M: Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc Natl Acad Sci USA 78:6623, 1981
58. Gafford JT, Skidgel RA, Erdos EG, Hersh LB: Human kidney "enkephalinase," a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22:3265, 1983
59. Hersh LB: Reaction of opioid peptides with neutral endopeptidase ("enkephalinase"). J Neurochem 43:487, 1984
60. von Boehmer H: Thymic selection: A matter of life and death. Immunol Today 13:454, 1992
61. Salles G, Rodewald HR, Chin BS, Reinherz EL, Shipp MA: Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo. Proc Natl Acad Sci USA 90:7618, 1993
62. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinherz EL: CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88:10662, 1991
63. Mari B, Guerin S, Maulon L, Belhacene N, Farahi Far D, Imbert V, Rossi B, Peyron JF, Auberger P: Endopeptidase 24.11 (CD10/NEP) is required for phorbol ester-induced growth arrest in Jurkat T cells. Faseb J 11:869, 1997
64. Savill J: Apoptosis. Phagocytic docking without shocking [news; comment]. Nature 392:442, 1998
65. Lecoeur H, Ledru E, Prevost MC, Gougeon ML: Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods 209:111, 1997
66. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710, 1991
67. Laurent Crawford AG, Krust B, Muller S, Riviere Y, Rey Cuille MA, Bechet JM, Montagnier L, Hovanessian AG: The cytopathic effect of HIV is associated with apoptosis. Virology 185:829, 1991
68. Hashimoto F, Oyaizu N, Kalyanaraman VS, Pahwa S: Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 90:745, 1997